BTSG: BTIG Raises PT
BTIG maintains buy rating on BrightSpring Health and raises price target to $90
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
BTIG maintains buy rating on BrightSpring Health and raises price target to $90
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.